AU2002310292A1 - Novel treatment for neurological and psychiatric disorders - Google Patents

Novel treatment for neurological and psychiatric disorders

Info

Publication number
AU2002310292A1
AU2002310292A1 AU2002310292A AU2002310292A AU2002310292A1 AU 2002310292 A1 AU2002310292 A1 AU 2002310292A1 AU 2002310292 A AU2002310292 A AU 2002310292A AU 2002310292 A AU2002310292 A AU 2002310292A AU 2002310292 A1 AU2002310292 A1 AU 2002310292A1
Authority
AU
Australia
Prior art keywords
neurological
psychiatric disorders
novel treatment
novel
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002310292A
Inventor
William T Regenold
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Maryland at Baltimore
Original Assignee
University of Maryland at Baltimore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Maryland at Baltimore filed Critical University of Maryland at Baltimore
Publication of AU2002310292A1 publication Critical patent/AU2002310292A1/en
Abandoned legal-status Critical Current

Links

AU2002310292A 2001-06-05 2002-06-05 Novel treatment for neurological and psychiatric disorders Abandoned AU2002310292A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60/295,895 2001-06-05

Publications (1)

Publication Number Publication Date
AU2002310292A1 true AU2002310292A1 (en) 2002-12-16

Family

ID=

Similar Documents

Publication Publication Date Title
AU2003286611A1 (en) Cytomodulating peptides and methods for treating neurological disorders
SI1474416T1 (en) Dihydrobenzodiazepin-2-one-derivatives for the treatment of neurological disorders
AU2002356525A1 (en) Substituted amines for the treatment of neurological disorders
PL373626A1 (en) Treatment for central nervous system disorders
AU2001247474A1 (en) Compounds for the treatment of psychiatric or substance abuse disorders
AU2003297761A1 (en) Methods for treating neurological language disorders
AU8187701A (en) Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders
GB0007193D0 (en) Treatment of movrmrnt disorders
AU2002334870B8 (en) Combinations for the treatment of immunoinflammatory disorders
AU2001269799A1 (en) Methods for treating various eye disorders
AU3977700A (en) Method of treating neurological disorders
AU2001271887A1 (en) Methods for diagnosis and treatment of psychiatric disorders
AU1356201A (en) Treatment of hyperproliferative disorders
AU2002362115A1 (en) Composition and methods for treatment of neurological disorders
GB9926968D0 (en) Treatment of neurological disorders
AU2002229986A1 (en) Method of treating neurological diseases
AU2003278084A1 (en) Benzo(d)azepine derivatives for the treatment of neurological and psychiatric disorders
AU2080201A (en) Treatment of addiction disorders
SI1468686T1 (en) S-methyl-dihydro-ziprasidone for treatment of psychiatric disorders
AU2002310292A1 (en) Novel treatment for neurological and psychiatric disorders
AU2003297259A1 (en) Methods and compositions for treating neurological disorders
AU2002229795A1 (en) Method for treating sexual disorders
AU2002237894A1 (en) Methods of treating neurological disorders
AU2002242293A1 (en) Treatment of neurological disease
AU2001236909A1 (en) Method of treating disorders of the eye